Free Subscription to Health Content Weekly Perspective
Categories
- Advertising
- Clinical tools
- Clinical Trials
- CMS, HHS
- Conferences
- Consumer Health
- Databases
- DrugInfo
- EBM
- EHRs
- Elsevier
- Eprescribing
- Google Health
- Health Grades
- Health2.0
- Healthcare Publishing
- HealthCentral Network
- HealthIT
- Healthline
- HIE
- Infocommerce
- infodemiology
- Licensing
- long-term care
- medical devices
- Medical Research
- Medical Search
- Medical Tourism
- Microsoft HealthVault
- MU
- newspapers
- open data
- Payers
- PBM
- Personalized Medicine
- Pharma
- Physician directories
- Physicians
- Point-of-care Applications
- publishing
- RCM
- RevolutionHealth
- Sermo
- Social networking
- UpToDate
- WebMD
- Wiley-Blackwell
- Wolters-Kluwer
Archives
- August 2010
- July 2010
- June 2010
- May 2010
- March 2010
- February 2010
- January 2010
- December 2009
- November 2009
- October 2009
- September 2009
- August 2009
- July 2009
- June 2009
- May 2009
- April 2009
- March 2009
- February 2009
- January 2009
- December 2008
- November 2008
- October 2008
- September 2008
- August 2008
- July 2008
- June 2008
- May 2008
- April 2008
- March 2008
- February 2008
- January 2008
Blogroll
Archive for December, 2009
Headline Commentary Dec 14-31
- Posted December 31st 2009
- Comments (0)
- by Janice
Quadrant HealthCom, publisher of The Female Patient, announced Tuesday that it has acquired Dowden Professional Publications from Lebhar-Friedman.With the deal, Quadrant takes control of four medical journals and an events group. The journals are: OBG Management, Current Psychiatry, The Journal of Family Practice and Mayo Clinic Proceedings. Financial terms of the deal were not disclosed.
Thomas Goetz, exec editor of Wired, on why personalized medicine is really about personal data.
Mentions Polka, an iPhone app, that allows remote monitoring.
Really good interview, where Gomez talks frankly about outdated tech in hospitals/health IT (e.g., MUMPS) and talks about making CPOE easier to reap benefits of healthcare data-analytics.
From press release: “iGuard is a free, personal drug safety monitoring service that now provides 2 million consumers and caregivers with timely, personalized information about drug-drug interactions, drug-disease interactions, medication safety warnings, breaking safety news and medication recalls that may affect their health. In return, patients provide feedback on their medications to help researchers learn how to treat diseases better and minimize medication side effects. In 2009 alone, iGuard users have contributed toward 92 medical research studies – helping to develop new drugs for such diseases as multiple sclerosis, epilepsy and diabetes.”
HealthGrades announces new org structure and provides improved guidance for 2010. I just have to add that this may be the most poorly written press release I have ever seen.
Healthy Humans (www.healthyhumans.com), an online wellness solutions company, received the 2009 Life Sciences Startup Company of the Year award from the Eastern Technology Council. The award, sponsored by the University of Sciences in Philadelphia, recognizes the company’s business and technology achievements. Healthy Humans provides online wellness programs that address the underlying causes of chronic disease and encourage prevention through personalized solutions and self-care methodologies. The company’s proprietary portal technology combines state-of-the-art medical protocols with evidence-based therapies. Note, Healthy Humans was highlighted as a Health Content08 Innovator at our HC08 conference.
CVS’ underperforming PBM unit names Lofberg new CEO. Lofberg is currently CEO of Generation Health, a genetic PBM.
Cerner acquires IMC Health Care, a provider of on-site health clinics for employers. Cerner established its own subsidiary to handle its self-insured and health & wellness needs. With acq. of IMC, Cerner is expanding to serve other self-insured employers.
Choronicle of Higher Ed describes some alternatives to impact factors. I agree that empirical data should be used in measuring importance, but a single # is not likely to be sufficient. Wouldn’t that strengthen the “Britney effect”?
Jane Sarasohn-Kahn on PWC’s new report on 10 top trends in healthcare in 2010. Link to full report included.
At least one doctor thinks they are. Dr. Wes Fisher writes that the rise of social media and the cost of travel (and reduction of sponsorship by pharma and device companies) spells the end of the medical conference business. I think he’s right that there will be a reduction in live events, but I don’t expect them to disappear.
More on HHS grant for designing db for comparative effective research.
HHS has an RFP for study on how to build claims db that will include payer records beyond CMS data. DB will be used for comparative effectiveness research (CER).
Nice comparison table of existing e-book readers.
Health Data Management reports that Thomson Reuters Healthcare (Ann Arbor) is entering the HIE market with a data analytics platform.
Good article that describes how electronic laboratory notebooks (ELN) could become the foundation for effective data management in R&D enterprises.
Healthcare IT News briefly reviews the top 20 list from KLAS.
Pfizer is equipping detailers with tablet computers that limit what samples can be provided to physicians based on their specialty and record the amount and type of samples. Doctors have to sign for receipt. It’s astonishing that sampels given to doctors in the past were not recorded!
A must-read for every publisher to gain an understanding of the convergence of publishing, marketing/advertising and the blurring of the roles between publishers and vendors. Nike’s online campaign was much more than advertising, it included tools for fitness programs and for exchanging data. Or as AdWeek says, “a product experience”. Traditional publications and ads can’t deliver a “product experience” in print of online.
A.D.A.M., long-known for its collection of anatomy images for medical education, launches an e-commerce enabled website that sells individual images. Prices seem to depend on the image and use. An graphic with multiple images related to carpal tunnel is priced at $39.95 for use in PPT; a simple image of the eye related to radial keratomy appears to be free, but site asked user to indicate how the image will be used.
Health Content Advisors ranks #136 out of 400 top blogs on IT. Interesting that my writings about health content, which is inextricably connected to health IT, rates so highly. It’s an honor to be placed in the immediate neighborhood of top analysts from top IT research firms, considering that my blog is secondary to the consulting work I do. Must be my analytical nature!
Very interesting. “December 14, 2009 — Lippincott Williams & Wilkins (LWW), a leading international publisher for healthcare professionals and students, and part of Wolters Kluwer Health, has partnered with ProtoMED Medical Management Corporation (PMMC) to build a student version of its ProtoMED medical practice management software and its ProtoCHART electronic medical record (EMR) software.”
Nice tribute to Paul Samuelson in the Boston Globe. Samuelson taught at MIT since 1940 and every student of economics has been touched by Dr. Samuelson. I honor him as a fellow U. Chicago alum, but also for negotiating one of the best textbook contracts ever.
NY Times highlights the conundrum of Wm Styron’s estate where Random House and Styron’s family both claim ownership of e-book rights. I was involved in licensing books for an early e-book reader (SoftBook Press) in the late ’90s and met with all of the major NY & Boston publishing houses, including Random House. At that time, the majority of recent contracts with authors included incomplete clauses that essentially wrote that the publisher had rights to new electronic formats for the content licensed in the contract with terms to be negotiated. It was a terrible situation where rights were tied up but terms and conditions weren’t defined. It seems as though these same publishers have done very little in the past decade to update the terms of contracts that existed at that time, at least with terms that are fair to authors. As in the B2B publishing world,B2C publishers (and authors and agents) have to recognize that the digital version of the work is now the primary work.
Open Data Will Be All the Rage in 2010
- Posted December 22nd 2009
- Comment (1)
- by Janice
Despite a dismal year for the media industry, there is one major trend we can all look forward to in 2010: Open Data.
Open data is more than a trend; it represents a shift in worldview about using research, business intelligence, and outcomes data. Tim Berners-Lee’s talk at TED in early 2009 promoted the power of raw data and described why we need to improve interoperability because “data are relationships” and analysis across larger collections of data help make “the world run better”.
At InfoCommerce Group we’ve always understood the importance of data and data management. Our roots go back to pre-Web 1.0 days when large print directories and buyers guides like the Thomas Register were being digitized. We’ve always understood that all digital content can be viewed as data whose value is increased when organized, categorized, sorted, modeled, analyzed, integrated, archived, updated–and shared.
In the healthcare industry, where I focus most of my attention, the possibilities for making the world run better by exploiting research, outcomes, and administrative data are enormous. Yet, the healthcare sector lags other industries by more than a decade in data management, data access and interoperability. (See: HISTalk interview with John Gomez, EVP/CTO Eclipsys, for frank talk on this issue.)
Support from HITECH funding surely will accelerate development of systems that enable data exchange and analysis in the healthcare industry. There are a lot of perceptions, attitudes and organizational changes that needs to occur, too; but there is no excuse for healthcare to continue to lag so far behind other industries in employing technology to improve performance.
Note, I just discovered a post by Jonathan Rosenberg, SVP, Product Management at Google, titled, “The Meaning of Open”. It’s a long post and I haven’t digested it yet, but will leave you with an outtake from the post [emphasis mine]:
“Open will win. It will win on the Internet and will then cascade across many walks of life: The future of government is transparency. The future of commerce is information symmetry. The future of culture is freedom. The future of science and medicine is collaboration. The future of entertainment is participation. Each of these futures depends on an open Internet.”
The impact of open data will reverberate throughout the publishing industry and is certain to be felt very strongly in the scholarly publishing sector, which currently dominates the distribution of medical research information. While it doesn’t spell disaster for this sector, it will impact traditional business models and relationships between researchers and publishers in a big way.
Happy holidays to everyone and best wishes for a brighter 2010!
Reinventing Business Publishing: HBR Relaunches
- Posted December 18th 2009
- Comments (0)
- by Janice
Last night I attended a TweetUp to celebrate the launch of the redesigned Harvard Business Review (HBR) and came away with renewed hope for the future of established publishers. The first decade of the 21st century has not delivered many positive stories about publishers who have dominated in the past, even those with iconic brands, but from what I’ve seen of the changes at the Harvard Business Review Group, there is hope that the next decade will include more stories with positive endings.
On the surface, the redesigned HBR is glossier than the former publication. It resembles other business magazines such as Forbes in other ways, too, including the advertisements (should I mention the unfortunate Accenture ad with Tiger Woods in the Jan-Feb 2010 issue of HBR?).
However, the changes that matter most run deeper and can be found online. The new Harvard Business Review site aggregates content from what used to be two separate sites, which among other things allows for the creation of “Author Pages” that “give … a deeper view of the [authors’] contributions across the magazine, the site and our books”.(1)
One could say that a “digital first” attitude is at the core of the change in direction at HBR. On a fundamental level, HBR has shifted from being organized around the type of publication (book, magazine, case study, etc.) to organizing around the needs of its audience. As obvious as it sounds, most traditional publishers have not yet made this change.
On a lighter note, my spirits were lifted when Eric Hellweg, the editor of HBR.org, greeted me by name at last night’s event. We had never met, but he explained that I was showcased in an internal meeting because of my retweet of their post on Twitter to promote the TweetUp. Apparently, the marketing folks wanted to emphasize that Twitter can be an effective tool in reaching their target audience. It was fun to know that I played a role in proving the power of Twitter and social media to Eric and the team at HBR!
Follow Harvard Business Review on Twitter @HarvardBiz
Finally, thanks to Siobban Ford of HBR.org for organizing last evening’s event at the Asgard Pub in Cambridge.
(1) See: The New Harvard Business Review Site.
Headline Commentary Dec 6-13
- Posted December 13th 2009
- Comments (0)
- by Janice
Press Ganey acquires Patient Impact, announced 12/6/09. Patient Impact to become the unit specializing in physician practice & outpatient surveys. More details to come. Note, Patient Impact was a Health Content Innovator and presented at our Health Content08 conference: http://www.infocommercegroup.com/healthcontent/index.html
Headline says it all. Gary dissects an actual memo used with TV journalists that promotes tying recent medical research to exaggerated claims of short-term benefits–and the specifically recommends against mentioning research labs or clinical work.
No doubt CME needs a redesign to change the current heavy subsidies by Pharma.
Article on the new building extension of MIT’s media lab designed by Japanese architect Fumihiko Maki. Contrasts Maki’s style of open space with lots of glass to original IM Pei buildling with limited windows. Interesting metaphor for move of technology from “black box” to enabling and thriving on “transparency”.
Article questions the affordability of new cancer drug, Folotyn, produced by Allos Therapeutics. Allos says price is in line with other specialty treatments and so far health insurers have agreed to cover it to treat aggressive tumors. Shines light on problem of high cost of developing drugs, but doesn’t offer any solutions.
An indictment of doctors and drug companies that promote drug interventions for preventive care. Uses example of hormone drug replacement for women.
Ad Age lists top magazines that have ceased publishing in 2009.
References CBO study (with link) that describes the allocation of marketing $$ to detailing, CME support, DTC and a measly $400 M in professional journals. Journals publishers need to reinvent themselves as a vehicle for reaching doctors/clinicians.
EBSCO’s DynaMed write-up on breast cancer screening. I don’t find their analysis and coverage very helpful.
Conversation between Milken and Pfizer CEO Kindler
Reports of small survey of device manufacturers; results show that social media isn’t yet part of the marketing mix for device companies.
John Moore writes a brief post about MSFT’s announcement of long-term care provider Golden Living’s adoption of Amalga & HealthVault.
Some commentary on benefits of move to ICD10 codes.
McClellan, former CMS adminstrator, MD, and PhD economist, will keynote Advanstar’s Center for Business Intelligence (CBI)’s Annual Strategic Medicare Policy Summit.
Good overview with links to other stories about Pharma’s slowness in developing mobile apps.
Nancy McKinstry interview: journals renewals are strong even with price increases; hospitals are spending more capital in 2009 than 2008 in anticipation of ARRA funds to come in 2010.
Note, this is the first I’ve heard of ebizMBA, who writes on their site that ebizMBA is “an eBusiness knowledgebase that helps you find the webs best ansers to your online business questions on topics ranging from online marketing and analytics to website development and venture capital”. To their credit, they offer some indication of the parameters they use to measure popularity.
Humana will establish MinuteClinic for its own employees and will encourage all members to use MinuteClinic for basic screening tests for cholesterol, blood pressure, bmi–and will couple basic screenings with its own LifeSynch health coaching.
Ovid to announce Universal Search, which allows clients to search across Ovid and client’s other internal databases in single search. Nice development.
WebMD, HealthVault (MSFT) and GoogleHealth comprise the panel moderated by Jane Sarasohn-Kahn. About 50 minutes long. Worth a look.
Not surprising to hear that Informa has decided against going forward with bid for Springer. Debt levels of Springer make the deal hard to digest and current Springer owners PE firms Candover and Cinven want a sale to conclude quickly. If PE company acquires Springer, perhaps they would sell off pieces.
Very good analysis of trends in IT research. Essentially says that high priced IT research reports are becoming commoditized and used for lead gen that is paid for by vendors. Analysts can still make money consulting, firms can put on events, and carry out customized research. Totally in line with my writings and demonstrated in the content value pyramid in my Publishing for e-Patients preso (on Slideshare/janicemc). Like comment about individual analysts becoming branded more so than firms. Agree there, too.
Dow Jones Venturesource reports Q2 2009 VC investments by industry. Healthcare the best performer and it outpaces IT for first time on record.
Kent Bottles provides excellent summary of recent lecture by David Eddy, MD (the “founder” of EBM) who has consistently challenged the robustness of existing methods of clinical decision guidelines. Dr. Eddy believes the future requires more complex models that consider a larger number of factors and interactions that in effect provide more personalized medical treatment. Eddy’s own company, Archimedes, builds “virtual patients” that can be used for complex modeling of probable outcomes. I don’t know enough about Archimedes to judge its efficacy, but I think Eddy has the right approach. We know that more data are available about patients and outcomes and will accelerating adoption of EHRs, the amount of data will expand rapidly. Along with the improved data sources, there is clearly a need for more complex models to analyze the data and test the benefits of medical treatments.
Good article with data and charts on changes in pharma sales & marketing over time and expected effects of health reform on pharma sales techniques.
Comprehensive article on HSAs and high-deductible health plans.
Perspective on whether use of EMRs reduce liability for physicians. Focuses on discounts offered by insurance cos to doctors and practices that use EMRs.
Schein will merge its animal health business with Butler; Schein to own 50.1%.
Press releases doesn’t provide many details; I will look at Elsevier site soon. Embase is an index to biomedical research; relaunching as standalone product seems old-world.
Good article that mentiones pricedoc.com, healthcarebluebook.com, and outofpocket.com, sites that provide info on prices for various procedures or office visits by doctor.
Story about Full Yield, a wellness program for employers that provides its own food & nutrition programs. Story describes how Safeway, IBM, Pitney Bowes and others have saved money on health care costs via wellness programs. Major issue, however, is that these are companies that self-insure.
Another story that critiques overly simple health care rating schemes. IMO, ratings needs to be based on analysis of outcomes, using real data, not observations from a third-party, which are subject to error.
A one-sided critique of the shortcomings of EHR/EMR systems from Huffington Post. Whereas I agree that there are shortcomings, a more balanced report would have more credibility. Still, it offers some good basic info on what the feds are trying to do with ARRA funding.
Excellent post and comments. I just added my own comment (7th in list).
Article mentions strong interest in healthcare sector by PE. Do PE professionals smell, taste and feel an opportunity in healthcare, too?
Good commentary on public reaction to public health announcements and EBM. More “infodemiology”, that is, providing trustworthy information and monitoring public response to epidemics, is needed.
Excellent video presentation by Peter Norvig of Google. Data, semantics, search and much more.
IDC Health Insights report on EHR vendors ($4,500)
Interesting article and site (which I just discovered) about opportunities in scientific/medical writing and journalism. Site focuses on female scientists.
Sponsored by Google, survey lists most popular resources used to find medical info. Surprise! Search engine/Google is at the top, followed by peer-reviewed journals. No category for online clinical information resources, such as UpToDate, MDConsult, DynaMed, as far as I can see. If no breakout were given on survey, Search Engine category may incorporate these resources too.
Money-Driven Medicine site with free streaming version of the movie. Nice example of offering free streaming with promo for the paid DVD.
FDA would need legislative action to approve new db, but given the ability to track more data from electronic records and online user-input, federal db makes sense.
More on Informa bid for Springer from FT, which quotes analyts.
Study of search behavior indicates that online search is often used to confirm or refute one’s internal knowledge. Hm, sounds rather Bayesian to me.
With over 2.1B Euros in debt (8X EBITA), Springer is a loaded target. Bids are expected to be under 400M Euros. But bigger question is: is there sustained value in publishers of scholarly research, an sector that is being disrupted by new models of scholarly communication and research?
Good review of press related to new mammogram guidelines. Interesting that so many who say they want EBM, object when they don’t like the data. “Don’t like” often means they stand to lose business or stature.
Zynx Health’s order sets will be integrated with Keane’s Optimum EHR system thru this partership. Another example of embedding EBM info into EHRs.
Article describes how students are sharing for-fee medical articles in a Napster-type environment.
“It” in this case, is the information in medical journal articles. Really good article about what could be done to help add context to each medical journal article that reports on new research so that journalists, patients, and even doctors can better understand the implications.
With pressure from patient groups and regulators, hospitals have make significant progress in reducing hospital-acquired patient infections. Checklists and focus on solving the problem (using best practices from other institutions as one means) are noted as key to changing the procedures and culture at hospitals.
Study performed by Prof. Ashish Jha at HSPH and Catherine DesRoches at MGH indicates that using EHRs makes little difference in outcomes. This article goes on to point out that researchers also focus on the importance of changing processes & culture in hospitals to benefit from positive effects of using EMRs/EHRs. I’d add that hospitals and hospital systems that incorporate clinical information systems (order sets, point-of-care CDS) are more likely tho demonstrate improved outcomes. At this stage, not enough evidence-based content has been incorporated into EMR/EHRs.
MD who wrote this post suggests that Kolata’s article is biased toward the big pharma position, since her only sources were from pharma.
Recent Posts
- Consequences of Market Concentration in Healthcare
- Today’s Health Content Headlines
- TEDxBoston: It’s Not Just About Information
About InfoCommerce Group